Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycolic acid peel versus topical tretinoin for acanthosis nigricans
IRCT20221129056666N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of Glycolic acid and tretinoin in acanthosis nigricans, sponsored by Tehran University of Medical Sciences. Primary endpoints: Clinical improvement of lesions and Side effects. Started Dec 2022; status: completed.
02
Drugs
Glycolic acidtretinoin
03
Conditions
acanthosis nigricans
Beyond the preview
Go deeper on IRCT20221129056666N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221129056666N1.